Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Umbralisib

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    TG Therapeutics Backpedals on BLA for Lymphoma, Leukemia Treatment
    TG Therapeutics Backpedals on BLA for Lymphoma, Leukemia Treatment

    16 Apr 2022

    // Alex Keown BIOSPACE

    https://www.biospace.com/article/tg-therapeutics-backpedals-on-lymphoma-leukemia-treatment-drops-applications/

    Alex Keown BIOSPACE
    16 Apr 2022
    Share Share
    FDA investigate possible increased risk of death with lymphoma medicine
    FDA investigate possible increased risk of death with lymphoma medicine

    09 Feb 2022

    // PHARMAFILE

    http://www.pharmafile.com/news/606273/fda-investigate-possible-increased-risk-death-lymphoma-medicine

    PHARMAFILE
    09 Feb 2022
    Share Share
    TG Therapeutics Falls 30% As CEO Discloses Partial Clinical Hold
    TG Therapeutics Falls 30% As CEO Discloses Partial Clinical Hold

    28 Jan 2022

    // V. Singh YAHOO FINANCE

    https://finance.yahoo.com/news/tg-therapeutics-falls-30-ceo-173034141.html

    V. Singh YAHOO FINANCE
    28 Jan 2022
    Share Share
    TG Therapeutics Announces Publication of Results Integrated Safety of UKONIQ®
    TG Therapeutics Announces Publication of Results Integrated Safety of UKONIQ®

    23 Sep 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/09/23/2302166/8790/en/TG-Therapeutics-Announces-Publication-of-Results-from-an-Integrated-Safety-Analysis-of-UKONIQ-umbralisib-in-Blood-Advances.html

    GLOBENEWSWIRE
    23 Sep 2021
    Share Share
    TG seeks US FDA approval for Ublituximab in combo with Umbralisib
    TG seeks US FDA approval for Ublituximab in combo with Umbralisib

    02 Dec 2020

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=133883&sid=2

    PHARMABIZ
    02 Dec 2020
    Share Share
    TG Therapeutics Announces Publication of Phase 2 Data Evaluating Umbralisib
    TG Therapeutics Announces Publication of Phase 2 Data Evaluating Umbralisib

    02 Dec 2020

    // TGTHERAPEUTICS

    https://ir.tgtherapeutics.com/news-releases/news-release-details/tg-therapeutics-announces-publication-phase-2-data-evaluating

    TGTHERAPEUTICS
    02 Dec 2020
    Share Share